ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Eli Lilly and Company clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 2,262 studies whose lead sponsor is Eli Lilly and Company or one of 22 companies grouped under it. 174 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 23 registry names, not the registry’s. See them and correct one ↓

Compare Eli Lilly with AstraZeneca and AbbVie →

Pipeline: 93 programs

Each counted once: 87 with a study Eli Lilly and Company leads registered in the last two years, 6 more from Eli Lilly and Company's own pipeline.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)
  • Named by Eli Lilly and Company only (no registered study yet; not in the 93)

The 5 of 13 with the most live studies.

Program
orforglipronPhase 3 · 17 live · Obesity · primary completion Feb 2027☆ Track
eloralintidePhase 3 · Eli Lilly and Company: Phase 3 · 17 live · Obesity · primary completion Dec 2026☆ Track
brenipatidePhase 3 · Eli Lilly and Company: Phase 3 · 16 live · Depressive Disorder, Major · primary completion Nov 2026☆ Track
retatrutidePhase 3 · Eli Lilly and Company: Phase 3 · 10 live · Obesity · primary completion Nov 2026☆ Track
ImlunestrantPhase 3 · 6 live · Breast Neoplasms · primary completion Aug 2027☆ Track

8 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Eli Lilly and Company’s own registered studies; “Eli Lilly and Company says” is its pipeline, which lists phases by indication. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

2 of Eli Lilly’s programs have a dated deal behind them: 1 brought in, 1 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Brought in 1

Licensed out 1

What it is testing

The drugs Eli Lilly and Company’s studies test, most open studies first — 276 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 276; every drug is on its own page, and each page lists its sponsors.

Coming up

104 of Eli Lilly and Company’s studies under way reach primary completion within a year, 24 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 10N’26
  2. 8D
  3. 3J’27
  4. 7F
  5. 6M
  6. 6A
  7. 8M
  8. 10J
  9. 6J
  10. 12A
  11. 13S
  12. 7O
  13. 8N

The 12 nearest

Show 7 more

Add all 104 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

Newly registered18

Show 13 more

All 2,262 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1748%Recruiting 148 · Not yet recruiting 21 · Enrolling by invitation 5
  • Under way, not recruiting1025%
  • Completed1,79980%
  • Stopped early1708%Terminated 144 · Withdrawn 26
  • Status unknown or other171%Approved for marketing 10 · Available 3 · No longer available 3 · Status unknown 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 11710
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 11226

By the year each study started; 406 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Eli Lilly and Company.

  • Eli Lilly and Company
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2,111 studies
  • Avid Radiopharmaceuticals
    Acquired — became part of Eli Lilly and Company, Dec 20, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    54 studies →
  • Loxo Oncology, Inc.
    Acquired — became part of Eli Lilly and Company, Feb 15, 2019 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    17 studies →
  • Adverum Biotechnologies, Inc.
    Acquired — became part of Eli Lilly and Company, Dec 9, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Dermira, Inc.
    Acquired — became part of Eli Lilly and Company, Feb 20, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    Acquired — became part of Eli Lilly and Company, Aug 9, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Centessa Pharmaceuticals (UK) Limited
    Acquired — became part of Eli Lilly and Company, Jun 24, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Beckley Psytech Limited
    Acquired — became part of Eli Lilly and Company, Sep 11, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Prevail Therapeutics
    Acquired — became part of Eli Lilly and Company, Jan 22, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
    Acquired — became part of Eli Lilly and Company, Aug 16, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • Verve Therapeutics, Inc.
    Acquired — became part of Eli Lilly and Company, Jul 25, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Zomagen Biosciences Ltd.
    Acquired — became part of Eli Lilly and Company, Mar 4, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
    Acquired — became part of Eli Lilly and Company, Mar 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • atai Therapeutics, Inc.
    Acquired — became part of Eli Lilly and Company, Sep 11, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Ventyx Biosciences, Inc
    Acquired — became part of Eli Lilly and Company, Mar 4, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
    Acquired — became part of Eli Lilly and Company, Dec 26, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Curevo Inc
    Acquired — became part of Eli Lilly and Company, Jul 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
    Acquired — became part of Eli Lilly and Company, Jun 10, 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Akouos, Inc.
    Acquired — became part of Eli Lilly and Company, Dec 1, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • SiteOne Therapeutics, Inc.
    Acquired — became part of Eli Lilly and Company, Jul 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Merida Biosciences
    Acquired — became part of Eli Lilly and Company, Oct 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Orna Therapeutics, Inc.
    Acquired — became part of Eli Lilly and Company, May 2026 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Eli Lilly and Company leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 66 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 2,262. Browse all 2,262 →